Here, thyroid carcinomas, small-cell lung cancer, gastrointestinal stromal tumours and endometrial carcinomas displayed noticeable C5aR1 expression in a high percentage of samples. This evidence concerns the gene C5AR1 and gastrointestinal stromal tumor.